Site icon pharmaceutical daily

World Clinical Trials Racial Representation Data Study 2022: The Importance of Diversity in Clinical Trials – Analysis of Racial Representation Across Multiple Clinical Trial Sectors – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trials – The Importance of Diversity in Clinical Trials” report has been added to ResearchAndMarkets.com’s offering.

This report provides an analysis of clinical trial racial representation data and evaluates racial demographics across a number of clinical trials sectors to highlight the level of diversity.

The clinical trials data used for these analyses was extracted from the publisher’s Clinical Trials Database, captured on June 16 and July 19, 2022. The data primarily includes clinical trials initiated from January 1, 2013 to June 16, 2022.

Disclosed racial representation data has been analyzed by location, by year, phase, therapy area, sponsor type, top industry sponsors, pivotal study status, single country and multinational trials, decentralized trials, and CRO involvement.

Additional analysis on obstacles in the recruitment of diverse subject populations in clinical trials and steps which can be taken to increase diversity have also been included.

Reasons to Buy

Key Topics Covered:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/64yhu2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version